Share Price and Basic Stock Data
Last Updated: December 5, 2025, 7:27 pm
| PEG Ratio | -1.84 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Arex Industries Ltd operates within the textile processing and texturising sector, a space characterized by its demand for innovation and efficiency. The company’s revenue trajectory has shown variability over the past few quarters. For instance, sales peaked at ₹12.80 Cr in September 2023, reflecting a robust recovery from the ₹10.96 Cr recorded in September 2022. However, the most recent quarterly figure of ₹12.34 Cr in September 2024 indicates a slight decline from the peak, a trend that may raise eyebrows among investors. Over the last fiscal year, revenue stood at ₹51.01 Cr, marginally up from ₹45.02 Cr in FY 2023, suggesting that while growth is present, it remains tepid. Given the competitive landscape of the textile industry, Arex will need to maintain agility and innovation to sustain its revenue growth.
Profitability and Efficiency Metrics
Arex Industries has demonstrated a mixed performance in terms of profitability. The operating profit margin (OPM) stood at 15.08% in FY 2025, a slight improvement from the previous year’s 15.15%. The operating profit reported was ₹8.15 Cr for FY 2025, which may appear reasonable, yet it reflects a decline from ₹9.08 Cr in FY 2024. The net profit margin, recorded at 5.15%, is solid but reveals a decline from 6.87% in FY 2022. Additionally, the return on equity (ROE) at 10.26% and return on capital employed (ROCE) at 14.40% suggests that while the company is generating returns, they are not particularly high compared to industry standards. The cash conversion cycle (CCC) of 138.57 days indicates a somewhat stretched working capital management, which could be a potential area for improvement.
Balance Sheet Strength and Financial Ratios
Examining Arex’s balance sheet reveals a company that is managing its liabilities effectively, with total borrowings at ₹10.72 Cr, which is relatively low compared to its reserves of ₹23.32 Cr. This translates to a debt-to-equity ratio of 0.48, indicating a conservative approach to leveraging. The interest coverage ratio (ICR) of 8.13x stands out, showcasing that Arex comfortably meets its interest obligations, which is a good sign for risk-averse investors. However, the decline in reserves from ₹27.65 Cr in FY 2024 to ₹22.07 Cr in FY 2025 may raise concerns regarding future investment capabilities. The current ratio of 1.32 indicates that Arex is in a comfortable position to cover its short-term liabilities, but the quick ratio of 0.74 suggests potential liquidity challenges that investors should monitor closely.
Shareholding Pattern and Investor Confidence
Arex Industries has a stable shareholding structure, with promoters holding a significant 70.60% stake as of June 2025. This strong promoter backing can instill confidence among retail investors, as it suggests alignment of interests. The public shareholding stands at 29.38%, reflecting a healthy level of market participation. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) might raise flags regarding broader market confidence in the stock. The number of shareholders has seen fluctuations, with a notable drop from 2,641 in September 2024 to 2,408 in June 2025, potentially indicating a lack of enthusiasm among retail investors. While the promoter’s commitment is commendable, the overall investor sentiment appears cautious, which may affect liquidity and market perception.
Outlook, Risks, and Final Insight
Looking ahead, Arex Industries faces a dual-edged sword of opportunities and challenges. On one hand, the textile industry is poised for growth driven by increasing domestic consumption and export potential. However, the company’s ability to capitalize on these trends will depend on its operational efficiency and innovation. Risks include the potential for fluctuating raw material costs and competitive pressures that could squeeze margins further. Additionally, the company’s stretched cash conversion cycle could pose liquidity challenges if not addressed. Investors should weigh these factors carefully. While there are strengths in the balance sheet and a stable promoter holding, the overall sentiment and operational metrics suggest a cautious approach is warranted. Careful monitoring of upcoming quarterly results will be essential to gauge whether Arex can navigate these challenges successfully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Arex Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minaxi Textiles Ltd | 7.91 Cr. | 1.60 | 2.55/1.43 | 4.12 | 0.82 | 0.00 % | 2.20 % | 42.3 % | 1.00 |
| Gujarat Cotex Ltd | 11.6 Cr. | 8.17 | 24.5/6.72 | 17.6 | 5.36 | 0.00 % | 3.59 % | 3.26 % | 5.00 |
| Gini Silk Mills Ltd | 37.2 Cr. | 66.5 | 165/62.1 | 20.4 | 91.2 | 0.00 % | 3.23 % | 2.24 % | 10.0 |
| Dhanlaxmi Fabrics Ltd | 49.6 Cr. | 57.8 | 70.5/52.6 | 53.1 | 0.00 % | 8.07 % | 8.90 % | 10.0 | |
| Bluechip Tex Industries Ltd | 25.2 Cr. | 128 | 191/120 | 130 | 0.00 % | 4.77 % | 5.30 % | 10.0 | |
| Industry Average | 1,243.29 Cr | 124.77 | 75.23 | 81.67 | 0.32% | 11.05% | 12.54% | 7.18 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.01 | 10.96 | 11.19 | 10.87 | 11.68 | 12.80 | 13.05 | 13.48 | 12.97 | 12.34 | 13.20 | 12.64 | 11.27 |
| Expenses | 9.73 | 9.71 | 9.26 | 9.40 | 9.82 | 10.40 | 9.53 | 12.16 | 10.48 | 10.97 | 10.62 | 10.88 | 9.57 |
| Operating Profit | 2.28 | 1.25 | 1.93 | 1.47 | 1.86 | 2.40 | 3.52 | 1.32 | 2.49 | 1.37 | 2.58 | 1.76 | 1.70 |
| OPM % | 18.98% | 11.41% | 17.25% | 13.52% | 15.92% | 18.75% | 26.97% | 9.79% | 19.20% | 11.10% | 19.55% | 13.92% | 15.08% |
| Other Income | 0.04 | -0.00 | 0.02 | 0.07 | -0.00 | -0.00 | -0.00 | 0.09 | -0.00 | 0.65 | -0.00 | 0.04 | -0.00 |
| Interest | 0.51 | 0.49 | 0.45 | 0.36 | 0.40 | 0.36 | 0.32 | 0.25 | 0.26 | 0.16 | 0.35 | 0.32 | 0.29 |
| Depreciation | 1.07 | 1.08 | 1.08 | 1.00 | 1.07 | 1.10 | 1.08 | 0.91 | 1.00 | 1.00 | 1.00 | 1.13 | 1.06 |
| Profit before tax | 0.74 | -0.32 | 0.42 | 0.18 | 0.39 | 0.94 | 2.12 | 0.25 | 1.23 | 0.86 | 1.23 | 0.35 | 0.35 |
| Tax % | 33.78% | -21.88% | 28.57% | -0.00% | 28.21% | 18.09% | 30.66% | 88.00% | 32.52% | 33.72% | 20.33% | 25.71% | 25.71% |
| Net Profit | 0.49 | -0.25 | 0.29 | 0.17 | 0.28 | 0.77 | 1.47 | 0.03 | 0.83 | 0.57 | 0.98 | 0.26 | 0.25 |
| EPS in Rs | 1.24 | -0.63 | 0.73 | 0.43 | 0.71 | 1.95 | 3.71 | 0.08 | 2.10 | 1.44 | 2.48 | 0.66 | 0.63 |
Last Updated: August 19, 2025, 11:30 pm
Below is a detailed analysis of the quarterly data for Arex Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 11.27 Cr.. The value appears to be declining and may need further review. It has decreased from 12.64 Cr. (Mar 2025) to 11.27 Cr., marking a decrease of 1.37 Cr..
- For Expenses, as of Jun 2025, the value is 9.57 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.88 Cr. (Mar 2025) to 9.57 Cr., marking a decrease of 1.31 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.70 Cr.. The value appears to be declining and may need further review. It has decreased from 1.76 Cr. (Mar 2025) to 1.70 Cr., marking a decrease of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 15.08%. The value appears strong and on an upward trend. It has increased from 13.92% (Mar 2025) to 15.08%, marking an increase of 1.16%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.04 Cr..
- For Interest, as of Jun 2025, the value is 0.29 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.32 Cr. (Mar 2025) to 0.29 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Jun 2025, the value is 1.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.13 Cr. (Mar 2025) to 1.06 Cr., marking a decrease of 0.07 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.35 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.35 Cr..
- For Tax %, as of Jun 2025, the value is 25.71%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.71%.
- For Net Profit, as of Jun 2025, the value is 0.25 Cr.. The value appears to be declining and may need further review. It has decreased from 0.26 Cr. (Mar 2025) to 0.25 Cr., marking a decrease of 0.01 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.63. The value appears to be declining and may need further review. It has decreased from 0.66 (Mar 2025) to 0.63, marking a decrease of 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31.70 | 33.04 | 32.15 | 34.94 | 37.66 | 40.72 | 47.17 | 40.88 | 53.75 | 45.02 | 51.01 | 51.14 | 49.45 |
| Expenses | 23.16 | 25.22 | 24.44 | 26.45 | 29.62 | 31.10 | 37.89 | 34.02 | 42.53 | 38.20 | 41.93 | 42.99 | 42.04 |
| Operating Profit | 8.54 | 7.82 | 7.71 | 8.49 | 8.04 | 9.62 | 9.28 | 6.86 | 11.22 | 6.82 | 9.08 | 8.15 | 7.41 |
| OPM % | 26.94% | 23.67% | 23.98% | 24.30% | 21.35% | 23.62% | 19.67% | 16.78% | 20.87% | 15.15% | 17.80% | 15.94% | 14.98% |
| Other Income | -0.13 | 0.08 | 0.06 | -0.06 | 0.11 | 0.42 | 0.15 | 0.08 | 0.04 | 0.23 | 0.10 | 0.74 | 0.69 |
| Interest | 1.07 | 0.77 | 0.72 | 1.02 | 1.09 | 2.54 | 3.13 | 2.98 | 2.11 | 1.81 | 1.33 | 1.09 | 1.12 |
| Depreciation | 4.05 | 3.13 | 2.54 | 2.51 | 2.54 | 4.02 | 4.85 | 4.76 | 4.49 | 4.23 | 4.16 | 4.13 | 4.19 |
| Profit before tax | 3.29 | 4.00 | 4.51 | 4.90 | 4.52 | 3.48 | 1.45 | -0.80 | 4.66 | 1.01 | 3.69 | 3.67 | 2.79 |
| Tax % | 33.13% | 32.50% | 36.36% | 34.29% | 23.67% | 27.59% | 38.62% | 25.00% | 20.60% | 30.69% | 31.17% | 28.07% | |
| Net Profit | 2.20 | 2.69 | 2.87 | 3.22 | 3.45 | 2.52 | 0.88 | -1.00 | 3.70 | 0.70 | 2.54 | 2.63 | 2.06 |
| EPS in Rs | 5.56 | 6.80 | 7.25 | 8.13 | 8.71 | 6.37 | 2.22 | -2.53 | 9.35 | 1.77 | 6.42 | 6.64 | 5.21 |
| Dividend Payout % | 16.20% | 13.25% | 41.39% | 24.60% | 22.96% | 31.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 22.27% | 6.69% | 12.20% | 7.14% | -26.96% | -65.08% | -213.64% | 470.00% | -81.08% | 262.86% | 3.54% |
| Change in YoY Net Profit Growth (%) | 0.00% | -15.58% | 5.50% | -5.05% | -34.10% | -38.12% | -148.56% | 683.64% | -551.08% | 343.94% | -259.31% |
Arex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -2% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | -11% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | -13% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.60 | 3.60 |
| Reserves | 10.53 | 12.79 | 14.23 | 17.67 | 20.21 | 21.76 | 21.69 | 20.70 | 24.41 | 25.11 | 27.65 | 22.07 | 23.32 |
| Borrowings | 8.85 | 5.57 | 10.30 | 12.97 | 29.96 | 35.38 | 32.00 | 31.06 | 23.32 | 17.75 | 10.49 | 12.34 | 10.72 |
| Other Liabilities | 3.67 | 2.80 | 4.99 | 3.39 | 5.35 | 6.42 | 6.53 | 6.94 | 6.77 | 5.88 | 8.06 | 8.62 | 8.16 |
| Total Liabilities | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
| Fixed Assets | 15.07 | 13.68 | 17.68 | 20.15 | 17.78 | 46.36 | 43.21 | 39.41 | 36.14 | 33.39 | 30.36 | 26.99 | 24.85 |
| CWIP | 0.35 | 0.00 | 1.80 | 0.00 | 23.85 | 0.00 | 0.00 | 0.00 | 0.49 | 0.00 | 0.03 | 0.88 | 2.61 |
| Investments | 0.02 | 0.03 | 1.03 | 1.26 | 0.12 | 0.02 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 11.57 | 11.41 | 12.97 | 16.58 | 17.73 | 21.14 | 20.97 | 22.24 | 21.83 | 19.31 | 19.77 | 18.76 | 18.34 |
| Total Assets | 27.01 | 25.12 | 33.48 | 37.99 | 59.48 | 67.52 | 64.18 | 62.66 | 58.46 | 52.70 | 50.16 | 46.63 | 45.80 |
Below is a detailed analysis of the balance sheet data for Arex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.60 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.60 Cr..
- For Reserves, as of Sep 2025, the value is 23.32 Cr.. The value appears strong and on an upward trend. It has increased from 22.07 Cr. (Mar 2025) to 23.32 Cr., marking an increase of 1.25 Cr..
- For Borrowings, as of Sep 2025, the value is 10.72 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 12.34 Cr. (Mar 2025) to 10.72 Cr., marking a decrease of 1.62 Cr..
- For Other Liabilities, as of Sep 2025, the value is 8.16 Cr.. The value appears to be improving (decreasing). It has decreased from 8.62 Cr. (Mar 2025) to 8.16 Cr., marking a decrease of 0.46 Cr..
- For Total Liabilities, as of Sep 2025, the value is 45.80 Cr.. The value appears to be improving (decreasing). It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
- For Fixed Assets, as of Sep 2025, the value is 24.85 Cr.. The value appears to be declining and may need further review. It has decreased from 26.99 Cr. (Mar 2025) to 24.85 Cr., marking a decrease of 2.14 Cr..
- For CWIP, as of Sep 2025, the value is 2.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.88 Cr. (Mar 2025) to 2.61 Cr., marking an increase of 1.73 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 18.34 Cr.. The value appears to be declining and may need further review. It has decreased from 18.76 Cr. (Mar 2025) to 18.34 Cr., marking a decrease of 0.42 Cr..
- For Total Assets, as of Sep 2025, the value is 45.80 Cr.. The value appears to be declining and may need further review. It has decreased from 46.63 Cr. (Mar 2025) to 45.80 Cr., marking a decrease of 0.83 Cr..
Notably, the Reserves (23.32 Cr.) exceed the Borrowings (10.72 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.31 | 2.25 | -2.59 | -4.48 | -21.92 | -25.76 | -22.72 | -24.20 | -12.10 | -10.93 | -1.41 | -4.19 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68.62 | 62.53 | 80.27 | 82.21 | 79.96 | 94.12 | 82.64 | 103.21 | 64.10 | 66.00 | 68.41 | 57.60 |
| Inventory Days | 110.40 | 107.11 | 137.21 | 139.33 | 126.72 | 201.12 | 198.88 | 224.84 | 228.87 | 234.62 | 191.74 | 194.58 |
| Days Payable | 6.63 | 3.77 | 19.66 | 17.54 | 31.68 | 81.26 | 100.09 | 107.42 | 92.02 | 82.61 | 94.31 | 113.61 |
| Cash Conversion Cycle | 172.39 | 165.87 | 197.82 | 204.00 | 175.00 | 213.98 | 181.42 | 220.64 | 200.95 | 218.01 | 165.84 | 138.57 |
| Working Capital Days | 42.14 | 43.53 | 32.36 | 53.90 | 64.55 | 68.48 | 65.00 | 82.32 | 51.95 | 74.99 | 63.83 | 29.55 |
| ROCE % | 20.35% | 20.81% | 20.55% | 19.21% | 12.62% | 9.86% | 7.65% | 3.78% | 12.64% | 5.52% | 11.27% | 11.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Diluted EPS (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| Cash EPS (Rs.) | 18.80 | 16.93 | 12.47 | 20.69 | 9.49 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 71.34 | 79.85 | 73.43 | 71.66 | 62.28 |
| Revenue From Operations / Share (Rs.) | 142.11 | 128.86 | 113.73 | 135.78 | 103.26 |
| PBDIT / Share (Rs.) | 24.71 | 23.19 | 17.83 | 28.42 | 17.53 |
| PBIT / Share (Rs.) | 13.23 | 12.68 | 7.13 | 17.07 | 5.50 |
| PBT / Share (Rs.) | 10.19 | 9.33 | 2.55 | 11.75 | -2.04 |
| Net Profit / Share (Rs.) | 7.32 | 6.42 | 1.77 | 9.34 | -2.54 |
| PBDIT Margin (%) | 17.38 | 17.99 | 15.67 | 20.93 | 16.97 |
| PBIT Margin (%) | 9.30 | 9.84 | 6.27 | 12.57 | 5.32 |
| PBT Margin (%) | 7.16 | 7.23 | 2.24 | 8.65 | -1.97 |
| Net Profit Margin (%) | 5.15 | 4.98 | 1.55 | 6.87 | -2.45 |
| Return on Networth / Equity (%) | 10.26 | 8.04 | 2.41 | 13.03 | -4.07 |
| Return on Capital Employeed (%) | 14.40 | 12.41 | 6.68 | 14.64 | 4.24 |
| Return On Assets (%) | 5.64 | 5.07 | 1.32 | 6.32 | -1.60 |
| Long Term Debt / Equity (X) | 0.20 | 0.20 | 0.39 | 0.56 | 1.02 |
| Total Debt / Equity (X) | 0.48 | 0.33 | 0.61 | 0.82 | 1.07 |
| Asset Turnover Ratio (%) | 1.06 | 0.99 | 0.81 | 0.88 | 0.64 |
| Current Ratio (X) | 1.32 | 1.94 | 1.73 | 1.65 | 1.84 |
| Quick Ratio (X) | 0.74 | 1.12 | 0.88 | 0.86 | 1.12 |
| Inventory Turnover Ratio (X) | 1.80 | 1.73 | 1.46 | 1.74 | 1.72 |
| Interest Coverage Ratio (X) | 8.13 | 6.91 | 3.89 | 5.34 | 2.33 |
| Interest Coverage Ratio (Post Tax) (X) | 3.41 | 2.92 | 1.39 | 2.76 | 0.66 |
| Enterprise Value (Cr.) | 66.54 | 65.94 | 49.05 | 83.11 | 53.76 |
| EV / Net Operating Revenue (X) | 1.30 | 1.29 | 1.09 | 1.55 | 1.32 |
| EV / EBITDA (X) | 7.48 | 7.18 | 6.95 | 7.39 | 7.75 |
| MarketCap / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| Price / BV (X) | 2.12 | 1.76 | 1.09 | 2.12 | 1.12 |
| Price / Net Operating Revenue (X) | 1.06 | 1.09 | 0.70 | 1.12 | 0.67 |
| EarningsYield | 0.04 | 0.04 | 0.02 | 0.06 | -0.03 |
After reviewing the key financial ratios for Arex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Diluted EPS (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 18.80. This value is within the healthy range. It has increased from 16.93 (Mar 24) to 18.80, marking an increase of 1.87.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 71.34. It has decreased from 79.85 (Mar 24) to 71.34, marking a decrease of 8.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 142.11. It has increased from 128.86 (Mar 24) to 142.11, marking an increase of 13.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 24.71. This value is within the healthy range. It has increased from 23.19 (Mar 24) to 24.71, marking an increase of 1.52.
- For PBIT / Share (Rs.), as of Mar 25, the value is 13.23. This value is within the healthy range. It has increased from 12.68 (Mar 24) to 13.23, marking an increase of 0.55.
- For PBT / Share (Rs.), as of Mar 25, the value is 10.19. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 10.19, marking an increase of 0.86.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 7.32. This value is within the healthy range. It has increased from 6.42 (Mar 24) to 7.32, marking an increase of 0.90.
- For PBDIT Margin (%), as of Mar 25, the value is 17.38. This value is within the healthy range. It has decreased from 17.99 (Mar 24) to 17.38, marking a decrease of 0.61.
- For PBIT Margin (%), as of Mar 25, the value is 9.30. This value is below the healthy minimum of 10. It has decreased from 9.84 (Mar 24) to 9.30, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 7.23 (Mar 24) to 7.16, marking a decrease of 0.07.
- For Net Profit Margin (%), as of Mar 25, the value is 5.15. This value is within the healthy range. It has increased from 4.98 (Mar 24) to 5.15, marking an increase of 0.17.
- For Return on Networth / Equity (%), as of Mar 25, the value is 10.26. This value is below the healthy minimum of 15. It has increased from 8.04 (Mar 24) to 10.26, marking an increase of 2.22.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.40. This value is within the healthy range. It has increased from 12.41 (Mar 24) to 14.40, marking an increase of 1.99.
- For Return On Assets (%), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 5.64, marking an increase of 0.57.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.20.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.48. This value is within the healthy range. It has increased from 0.33 (Mar 24) to 0.48, marking an increase of 0.15.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.06. It has increased from 0.99 (Mar 24) to 1.06, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.94 (Mar 24) to 1.32, marking a decrease of 0.62.
- For Quick Ratio (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.74, marking a decrease of 0.38.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 4. It has increased from 1.73 (Mar 24) to 1.80, marking an increase of 0.07.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.13. This value is within the healthy range. It has increased from 6.91 (Mar 24) to 8.13, marking an increase of 1.22.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.41. This value is within the healthy range. It has increased from 2.92 (Mar 24) to 3.41, marking an increase of 0.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.54. It has increased from 65.94 (Mar 24) to 66.54, marking an increase of 0.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has increased from 1.29 (Mar 24) to 1.30, marking an increase of 0.01.
- For EV / EBITDA (X), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 7.18 (Mar 24) to 7.48, marking an increase of 0.30.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.76 (Mar 24) to 2.12, marking an increase of 0.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.06, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Arex Industries Ltd:
- Net Profit Margin: 5.15%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.4% (Industry Average ROCE: 11.05%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 10.26% (Industry Average ROE: 12.54%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.41
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.74
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.3 (Industry average Stock P/E: 75.23)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.48
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 5.15%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Textiles - Processing/Texturising | 612, GIDC Industrial Estate, Chhatral, Gandhi Nagar Dist. Gujarat 382729 | mail@arex.in http://www.arex.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dinesh A Bilgi | Managing Director & CFO |
| Mr. Neel D Bilgi | Managing Director |
| Mr. Chirag D Bilgi | Managing Director |
| Mr. Pragnesh K Shah | Director |
| Mr. Balkrishna Makwana | Independent Director |
| Mrs. Harsha H Parikh | Independent Director |
| Mr. Aviv J Divekar | Independent Director |
| Mr. Laxman C Tilani | Director |
| Mr. Manoj U Shah | Additional Director |
| Mrs. Rekha Agarwal | Addnl. Independent Woman Director |
| Mr. Sunil Bansibhai Shah | Addnl. & Ind.Director |
FAQ
What is the intrinsic value of Arex Industries Ltd?
Arex Industries Ltd's intrinsic value (as of 10 December 2025) is 112.51 which is 19.64% lower the current market price of 140.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 50.6 Cr. market cap, FY2025-2026 high/low of 177/129, reserves of ₹23.32 Cr, and liabilities of 45.80 Cr.
What is the Market Cap of Arex Industries Ltd?
The Market Cap of Arex Industries Ltd is 50.6 Cr..
What is the current Stock Price of Arex Industries Ltd as on 10 December 2025?
The current stock price of Arex Industries Ltd as on 10 December 2025 is 140.
What is the High / Low of Arex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Arex Industries Ltd stocks is 177/129.
What is the Stock P/E of Arex Industries Ltd?
The Stock P/E of Arex Industries Ltd is 20.3.
What is the Book Value of Arex Industries Ltd?
The Book Value of Arex Industries Ltd is 74.8.
What is the Dividend Yield of Arex Industries Ltd?
The Dividend Yield of Arex Industries Ltd is 0.00 %.
What is the ROCE of Arex Industries Ltd?
The ROCE of Arex Industries Ltd is 11.8 %.
What is the ROE of Arex Industries Ltd?
The ROE of Arex Industries Ltd is 9.08 %.
What is the Face Value of Arex Industries Ltd?
The Face Value of Arex Industries Ltd is 10.0.